Trade

with

Prosensa Holding NV
(NASDAQ: RNA)
AdChoices
11.94
+0.05
+0.42%
After Hours :
12.00
+0.06
+0.50%

Open

11.90

Previous Close

11.89

Volume (Avg)

178.58k (129.86k)

Day's Range

11.62-11.95

52Wk Range

3.43-13.32

Market Cap.

427.24M

Dividend Rate ( Yield )

-

Beta

-

Shares Outstanding

35.93M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 11.46M

    • Net Income

    • -21.30M

    • Market Cap.

    • 427.24M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -47.21

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -7.02

    • Price/Sales

    • 17.36

    • Price/Book Value

    • 5.27

    • Price/Cash flow

    • -13.89

      • EBITDA

      • -18.90M

      • Return on Capital %

      • -15.52

      • Return on Equity %

      • -25.54

      • Return on Assets %

      • -15.52

      • Book Value/Share

      • 2.90

      • Shares Outstanding

      • 35.93M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 26.70

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -2.16

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 514.80

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -47.21

            • 39.38

            • Net Profit Margin

            • -47.21

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.12

              • 0.76

              • Current Ratio

              • 13.64

              • 2.92

              • Quick Ratio

              • 13.43

              • 2.35

              • Interest Coverage

              • -11.17

              • 38.02

              • Leverage Ratio

              • 1.21

              • 2.21

              • Book Value/Share

              • 2.26

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -36.76

                • 196.08

                • P/E Ratio 5-Year High

                • -106.75

                • 634.30

                • P/E Ratio 5-Year Low

                • -10.60

                • 124.82

                • Price/Sales Ratio

                • 17.33

                • 9.12

                • Price/Book Value

                • 5.26

                • 8.26

                • Price/Cash Flow Ratio

                • -13.89

                • 47.39

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -25.54

                    (-)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -15.52

                    (-)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -19.30

                    (-)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • -

                  • 1.48

                  • Asset Turnover

                  • 0.33

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -21.27M
                  Operating Margin
                  -185.54
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -13.89
                  Ownership

                  Institutional Ownership

                  76.93%

                  Top 10 Institutions

                  70.99%

                  Mutual Fund Ownership

                  4.79%

                  Float

                  38.09%

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    712,025

                  • 41.76

                  • 1.98

                  • Fidelity Advisor® Biotechnology Fund

                  •  

                    151,216

                  • 36.03

                  • 0.42

                  • Franklin Biotechnology Discovery

                  •  

                    126,400

                  • 0.00

                  • 0.35

                  • BlackRock Health Sciences Opps Port

                  •  

                    77,600

                  • 0.00

                  • 0.22

                  • ZI BlackRock Global Fds Wld Health Sci

                  •  

                    39,100

                  • 0.00

                  • 0.11

                  • Tocqueville Opportunity

                  •  

                    35,000

                  • 0.00

                  • 0.10

                  • Polar Capital Biotechnology Fund

                  •  

                    14,492

                  • -20.08

                  • 0.04

                  • KBC Eq Fd Pharma

                  •  

                    7,067

                  • 0.00

                  • 0.02

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • NEA Management Company, LLC

                  •  

                    6,480,171

                  • 0.00%

                  • 18.03

                  • Abingworth LLP

                  •  

                    6,213,924

                  • 0.00%

                  • 17.29

                  • Deerfield Management Co

                  •  

                    2,206,119

                  • -31.30%

                  • 6.14

                  • Kempen Capital Management N.V.

                  •  

                    1,996,253

                  • 0.00%

                  • 5.56

                  • Millennium Management LLC

                  •  

                    887,553

                  • +3,182.25%

                  • 2.47

                  • Fidelity Management and Research Company

                  •  

                    355,812

                  • -5.45%

                  • 0.99

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  -

                  Style

                  Small Growth

                  Prosensa Holding NV is an biotechnology company engaged in the discovery and development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders.

                  Key People

                  Mr. Hans Schikan

                  CEO

                  David Mott

                  Chairman of the Board/Director

                  Mr. Berndt Modig

                  CFO

                  Dr. Georges Gemayel,PhD

                  Director

                  Mr. Patrick Van Beneden

                  Director

                  • Prosensa Holding NV

                  • J.H. Oortweg 21

                  • Leiden, 2333 CH

                  • NLD.Map

                  • Phone: +31 713322100

                  • Fax: +31 713322088

                  • prosensa.eu

                  Incorporated

                  0

                  Employees

                  89

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: